BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hansen K, Horslen S. Metabolic liver disease in children. Liver Transpl 2008;14:391-411. [DOI: 10.1002/lt.21470] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Mazariegos G, Shneider B, Burton B, Fox IJ, Hadzic N, Kishnani P, Morton DH, McIntire S, Sokol RJ, Summar M, White D, Chavanon V, Vockley J. Liver transplantation for pediatric metabolic disease. Mol Genet Metab 2014;111:418-27. [PMID: 24495602 DOI: 10.1016/j.ymgme.2014.01.006] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 8.1] [Reference Citation Analysis]
2 Nabors LA, Hoffman AR, Ritchey PN. Four illnesses: lenses for critical topics in child quality of life research. J Pediatr 2011;158:529-31. [PMID: 21232752 DOI: 10.1016/j.jpeds.2010.11.057] [Reference Citation Analysis]
3 Kaller T, Langguth N, Petermann F, Ganschow R, Nashan B, Schulz K. Cognitive Performance in Pediatric Liver Transplant Recipients: Cognitive Performance After Liver Transplant. American Journal of Transplantation 2013;13:2956-65. [DOI: 10.1111/ajt.12408] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
4 Alves-Bezerra M, Furey N, Johnson CG, Bissig KD. Using CRISPR/Cas9 to model human liver disease. JHEP Rep 2019;1:392-402. [PMID: 32039390 DOI: 10.1016/j.jhepr.2019.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
5 Mace H, Srinivas C, Selzner M, Minkovich L. Anesthetic management of a patient with arginase deficiency undergoing liver transplantation. A A Case Rep 2014;3:85-7. [PMID: 25611620 DOI: 10.1213/XAA.0000000000000066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 De Caneva A, Porro F, Bortolussi G, Sola R, Lisjak M, Barzel A, Giacca M, Kay MA, Vlahoviček K, Zentilin L, Muro AF. Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases. JCI Insight 2019;5:128863. [PMID: 31211694 DOI: 10.1172/jci.insight.128863] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
7 Rosencrantz R, Cimsit B, Seashore M, Arvelakis A, Kulkarni S, Ghiroli M, Emre S. Pediatric liver transplantation for inherited metabolic liver disease: a single-center experience. Transplant Proc 2011;43:896-900. [PMID: 21486623 DOI: 10.1016/j.transproceed.2011.02.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
8 Guerrero RB, Kloke KM, Salazar D. Inborn Errors of Metabolism and the Gastrointestinal Tract. Gastroenterol Clin North Am 2019;48:183-98. [PMID: 31046970 DOI: 10.1016/j.gtc.2019.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]